GH Research PLC (GHRS)
9.62
-1.33
(-12.15%)
USD |
NASDAQ |
Nov 21, 16:00
9.55
-0.07
(-0.73%)
Pre-Market: 20:00
GH Research Net Income (Quarterly): -12.11M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -12.11M |
| June 30, 2024 | -10.38M |
| March 31, 2024 | -7.666M |
| December 31, 2023 | -11.27M |
| September 30, 2023 | -5.649M |
| June 30, 2023 | -7.729M |
| March 31, 2023 | -10.94M |
| December 31, 2022 | -16.59M |
| September 30, 2022 | -0.441M |
| June 30, 2022 | 0.334M |
| Date | Value |
|---|---|
| March 31, 2022 | -5.763M |
| December 31, 2021 | -4.091M |
| September 30, 2021 | -1.837M |
| June 30, 2021 | -2.125M |
| March 31, 2021 | -1.149M |
| December 31, 2020 | -0.325M |
| September 30, 2020 | -0.06M |
| June 30, 2020 | -0.042M |
| March 31, 2020 | -0.019M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-16.59M
Minimum
Dec 2022
0.334M
Maximum
Jun 2022
-5.15M
Average
-4.091M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| Amarin Corp PLC | -25.13M |
| Jazz Pharmaceuticals PLC | 215.06M |
| Prothena Corp PLC | -59.00M |
| Iterum Therapeutics PLC | -7.101M |
| Mural Oncology PLC | -31.76M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 12.62M |
| EPS Diluted (Quarterly) | -0.23 |
| Enterprise Value | 350.47M |
| Earnings Yield | -8.21% |